Search research articles
Contact Us
Filters
Showing results (41-50 of 94) with videos related to
Page
of 10
Sort By:
European Urology
|
March 31, 2018
Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review
Netty Kinsella, Pär Stattin, Declan Cahill, et al.
BMJ Open
|
August 17, 2024
How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?
Emmeli Palmstedt, Marianne Månsson, Karin Stinesen Kollberg, et al.
Cancer Epidemiology
|
November 28, 2016
What explains the differences between centres in the European screening trial? A simulation study
Jaakko Nevalainen, Ulf-Håkan Stenman, Teuvo L Tammela, et al.
BJU International
|
May 12, 2015
Population-based study of long-term functional outcomes after prostate cancer treatment
Sigrid Carlsson, Linda Drevin, Stacy Loeb, et al.
European Urology Oncology
|
September 26, 2022
Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic Review
Daryl Thompson, Jonathan G Bensley, Jake Tempo, et al.
Scandinavian Journal of Urology
|
October 30, 2019
Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres
Kimia Kohestani, Jonas Wallström, Niclas Dehlfors, et al.
The Journal of Sexual Medicine
|
February 9, 2022
The Relationship Between PSA and Total Testosterone Levels in Men With Prostate Cancer
Jose M Flores, Helen L Bernie, Eduardo Miranda, et al.
BMC Urology
|
March 8, 2014
Effects of surgeon variability on oncologic and functional outcomes in a population-based setting
Sigrid Carlsson, Anders Berglund, Daniel Sjoberg, et al.
Journal of Medical Screening
|
October 25, 2012
Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality
Xiaoye Zhu, Pim J van Leeuwen, Erik Holmberg, et al.
The Journal of Urology
|
June 29, 2023
Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial
Kendrick Yim, Chaoran Ma, Sigrid Carlsson, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 94) with videos related to
Sort By:
Page
of 10
European Urology
|
March 31, 2018
Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review
Netty Kinsella, Pär Stattin, Declan Cahill, et al.
BMJ Open
|
August 17, 2024
How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?
Emmeli Palmstedt, Marianne Månsson, Karin Stinesen Kollberg, et al.
Cancer Epidemiology
|
November 28, 2016
What explains the differences between centres in the European screening trial? A simulation study
Jaakko Nevalainen, Ulf-Håkan Stenman, Teuvo L Tammela, et al.
BJU International
|
May 12, 2015
Population-based study of long-term functional outcomes after prostate cancer treatment
Sigrid Carlsson, Linda Drevin, Stacy Loeb, et al.
European Urology Oncology
|
September 26, 2022
Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic Review
Daryl Thompson, Jonathan G Bensley, Jake Tempo, et al.
Scandinavian Journal of Urology
|
October 30, 2019
Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres
Kimia Kohestani, Jonas Wallström, Niclas Dehlfors, et al.
The Journal of Sexual Medicine
|
February 9, 2022
The Relationship Between PSA and Total Testosterone Levels in Men With Prostate Cancer
Jose M Flores, Helen L Bernie, Eduardo Miranda, et al.
BMC Urology
|
March 8, 2014
Effects of surgeon variability on oncologic and functional outcomes in a population-based setting
Sigrid Carlsson, Anders Berglund, Daniel Sjoberg, et al.
Journal of Medical Screening
|
October 25, 2012
Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality
Xiaoye Zhu, Pim J van Leeuwen, Erik Holmberg, et al.
The Journal of Urology
|
June 29, 2023
Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial
Kendrick Yim, Chaoran Ma, Sigrid Carlsson, et al.
Page
of 10